Rare Disease Genetic Testing Market By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine and Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Disease, Others), Technology (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping), Specialty...

The global Alagille Syndrome Treatment Market focuses on therapies aimed at managing the symptoms and complications of Alagille Syndrome (ALGS), a rare, multi-system genetic disorder caused primarily by mutations in the JAG1 gene. ALGS is characterized by abnormalities in the liver, heart, eyes, skeleton, and kidneys, with the most common and severe manifestation being chronic cholestasis...

Introspective Market Research (IMR) today announced the release of its Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market Report , projecting a consistent expansion in this rare but clinically significant autoimmune disorder. IMR's analysis estimates that the APS-1 market — recently valued at USD 289.1 million (2025) according to  — will grow to approximately USD 362.8...

Introspective Market Research, a leader in pharmaceutical and healthcare intelligence, today published its deep-dive analysis into the Global Campomelic Syndrome Treatment Market . Campomelic Syndrome (CS) is a rare and often life-threatening genetic disorder characterized by severe skeletal malformations, which necessitates intensive supportive and specialized care. The market, which focuses...

Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market . The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million...